Changes in the liver transplant evaluation process during the early COVID-19 era and the role of telehealth

Table 4 Univariable and multivariable linear regression evaluating predictors of time to listing during coronavirus disease 2019 era among those ultimately listed

	Univariable beta	P value	Multivariable beta	P value
Age	0.2	0.72
Sex, male	-17.5	0.22
Preferred language, non-English	14.64	0.39
Race/ethnicity (ref: White)
Hispanic	-2.18	0.88
Asian	15.02	0.53
Other	-7.73	0.78
Insurance (ref: Private)
Medicare	35.96	0.02	17.46	0.02
Medi-cal	31.2	0.08	11.52	0.13
Hepatology visit type (ref: Office visit)
Telehealth	-15.1	0.37	2.1	0.79
Inpatient	-51.39	< 0.001	-33.78	< 0.001
MELD-Na at evaluation	-0.85	0.18
Distance to Stanford Hospital	-0.02	0.79
Alcohol etiology	32.48	0.02	13.54	0.03
HCC diagnosis	-24.26	0.13

MELD-Na: Model for end-stage liver disease with sodium; HCC: Hepatocellular carcinoma.